Article

Figures for Interest Grows in Treatment of Mood Disorders by Classic Psychedelics

Author(s):

Nicole Ledwos, MSc,M. Ishrat Husain, MD (Res), MBBS, MRCPsych

This is the extra table for "Interest Grows in Treatment of Mood Disorders by Classic Psychedelics."

Table. Registered Clinical Trials on ClinicalTrials.gov

Table. Registered Clinical Trials on ClinicalTrials.gov

Related Videos
Tasphong/AdobeStock
Andrii Yalaanskyi/AdobeStock
Jorm Sangsorn/AdobeStock
RolfImages/AdobeStock
CravenA/AdobeStock
brain
Related Content
COVID
March 11th 2025

Psilocybin Benefits Clinicians Traumatized on Front Line of COVID-19 Pandemic

Kenneth J. Bender, PharmD, MA
Here's to a Psychedelic Revolution
April 9th 2022

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
Psychiatric Times Through the Years: The Last 5 Years in February Covers
February 22nd 2025

Psychiatric Times Through the Years: The Last 5 Years in February Covers

Megan McSweeney
Blue Light, Depression, and Bipolar Disorder
August 4th 2021

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP
mania
February 19th 2025

Mania and Hypomania: Latest Thinking on Diagnosis and Duration of Episodes

David N. Osser, MD
Ronstik/AdobeStock
February 14th 2025

Week in Review: February 10-14

Megan McSweeney
© 2025 MJH Life Sciences

All rights reserved.